Nurse dead in Congo as Ebola vaccination campaign starts

A health worker wears protective clothing outside an isolation ward to diagnose and treat suspected Ebola patients, at Bikoro Hospital in Bikoro, the rural area where the Ebola outbreak was announced last week, in Congo. (Mark Naftalin/UNICEF via AP)
Updated 21 May 2018
Follow

Nurse dead in Congo as Ebola vaccination campaign starts

  • The have so far been 27 deaths in this latest outbreak of the killer disease
  • There are plans to distribute a vaccine which is due to have started Monday

DEMOCRATIC REPUBLIC OF CONGO: Congo’s health minister says a nurse has died from Ebola in Bikoro, the rural northwestern town where the outbreak began, as the country begins a vaccination campaign.

Health Minister Oly Ilunga said late Sunday that the nurse’s death brings the death toll to 27 since early April. There are now 49 hemorrhagic fever cases: 22 confirmed as Ebola, 21 probable and 6 suspected.

Ilunga said two patients have recovered from Ebola, returning home.

Congo’s health delegation, including the health minister, and representatives of the World Health Organization and United Nations have arrived in Mbandaka, the northwestern city of more than 1 million where Ebola has spread, to launch the vaccination campaign Monday. The ministry said it will take five days to target health care workers and 100 registered contacts in the city.

The World Health Organization (WHO) hailed the vaccinations as a “paradigm shift” in how to fight the disease which killed more than 11,300 people in a West African epidemic between 2013 and 2016.

The WHO is sending over 7,540 doses of the vaccine to the central African country, 540 of which have been earmarked for Mbandaka, a city of about 1.5 million where four Ebola cases have been confirmed.

In a ceremony attended by health minister Oly Ilunga Kalenga, health workers in blue overalls and rubber gloves administered the vaccine developed by US drug company Merck , marking the start of a complex effort to ring-fence the virus before it gets out of control.

The other vaccines will be given to medical staff later on Monday at a nearby hospital. People who had contact with Ebola victims will come later.
“This is a new phase in our response, another pillar in the fight. We must continue the monitoring of contacts,” Ilunga said.

Ebola causes hemorrhagic fever, vomiting and diarrhea and spreads through contact with the bodily fluids of an infected person. When a new case is diagnosed, all people who might have been in recent contact with the patient are traced and vaccinated to keep the disease from spreading.

WHO Director General Tedros Adhanom said the outlook for dealing with the new outbreak, the ninth in Congo since the disease made its first known appearance in the 1970s, was brighter than when the West African epidemic was reported.

Mbandaka lies on the Congo River with regular transport links to the Kinshasa, raising concerns that the virus could spread to the capital where 10 million people live. The need to keep the vaccine at 80 degrees Celsius below freezing (minus 112 Fahrenheit) in a humid region with erratic electricity supply has further complicated the operation.

“It’s concerning that we now have cases of Ebola in an urban center, but we are much better placed to deal with this outbreak than we were in 2014,” Tedros told health ministers at the start of the WHO’s annual assembly in Geneva.

The WHO’s head of emergency response Peter Salama said use of the VSV-EBOV shot means regions with Ebola outbreaks can in future expect more than just containment with basic public health measures such as isolation and hygiene.

“It’s the first time in the midst of an outbreak ... that we’re using this as a way to stem transmission,” Salama told Reuters in a telephone interview.

“It’s an important moment that changes the way we’ve seen Ebola for 40 years.”

Of the 46 people thought to have been infected so far in the latest outbreak, 26 have died, the WHO said. Of that caseload, 21 have been confirmed in a laboratory, 21 are regarded as probable Ebola cases, and four patients are suspected of having Ebola.

The WHO’s previous leadership was heavily criticized for its slow response to the outbreak that began in late 2013. The WHO did not call an emergency meeting for that outbreak until August 2014. 


SpaceX acquires xAI in record-setting deal as Musk looks to unify AI and space ambitions

Updated 03 February 2026
Follow

SpaceX acquires xAI in record-setting deal as Musk looks to unify AI and space ambitions

  • The deal is the biggest M&A transaction of all time
  • Deal values xAI at $250 billion, SpaceX at $1 trillion

Elon Musk said on Monday ​that SpaceX has acquired his artificial-intelligence startup xAI in a record-setting deal that unifies Musk’s AI and space ambitions by combining the rocket-and-satellite company with the maker of the Grok chatbot. The deal, first reported by Reuters last week, represents one of the most ambitious tie-ups in the technology sector yet, combining a space-and-defense contractor with a fast-growing AI developer whose costs are largely driven by chips, data centers and energy. It could also bolster SpaceX’s data-center ambitions as Musk competes with rivals like Alphabet’s Google, Meta, Amazon-backed Anthropic ‌and OpenAI in the ‌AI sector.
The transaction values SpaceX at $1 trillion, and ‌xAI ⁠at $250 ​billion, according ‌to a person familiar with the matter.
“This marks not just the next chapter, but the next book in SpaceX and xAI’s mission: scaling to make a sentient sun to understand the Universe and extend the light of consciousness to the stars!” Musk said. The purchase of xAI sets a new record for the world’s largest M&A deal, a distinction held for more than 25 years when Vodafone bought Germany’s Mannesmann in a hostile takeover valued at $203 billion ⁠in 2000, according to data compiled by LSEG. The combined company of SpaceX and xAI is expected to price shares ‌at about $527 each, another person familiar with the matter said. ‍SpaceX was already the world’s most ‍valuable privately held company, last valued at $800 billion in a recent insider share sale. ‍XAI was last valued at $230 billion in November, according to the Wall Street Journal. The merger comes as the space company plans a blockbuster public offering this year that could value it at over $1.5 trillion, two people familiar with the matter said.
SpaceX, xAI and Musk did not immediately respond ​to requests for comment.
The deal further consolidates Musk’s far-flung business empire and fortunes into a tighter, mutually reinforcing ecosystem – what some investors and analysts informally ⁠call the “Muskonomy” – which already includes Tesla, brain-chip maker Neuralink and tunnel firm the Boring Company. The world’s richest man has a history of merging his ventures together. Musk folded social media platform X into xAI through a share swap last year, giving the AI startup access to the platform’s data and distribution. In 2016, he used Tesla’s stock to buy his solar-energy company SolarCity.
The agreement could draw scrutiny from regulators and investors over governance, valuation and conflicts of interest given Musk’s overlapping leadership roles across multiple firms, as well as the potential movement of engineers, proprietary technology and contracts between entities.
SpaceX also holds billions of dollars in federal contracts with NASA, the Department of Defense and intelligence agencies, which all have some authority ‌to review M&A transactions for national security and other risks.